• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 HYPERGLIDE; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 HYPERGLIDE; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY Back to Search Results
Model Number 104-4310
Device Problems Burst Container or Vessel (1074); Inflation Problem (1310)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/26/2019
Event Type  malfunction  
Manufacturer Narrative
The device involved in the reported event has not been returned for evaluation; therefore, the event cause could not be determined.Correspondence has ben sent out to the customer.Once the device has been received and the investigation has been completed, a supplemental report will be submitted.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that the medtronic balloon occlusion system failed to inflate.Prior to the event, the balloon was prepared as indicated in the instructions for use (ifu) and then placed inside the patient.Once inside, the reported event occurred.Contrast was observed to be leaking out of the balloon.Upon removal of the balloon, physical inspection revealed that the balloon had ruptured causing it to leak the contrast.A balloon from another manufacture was used to complete the procedure.No patient injury was reported as a result of the event.
 
Event Description
Additional information was received: the balloon was tested prior to use and performed as intended.During inflation the guidewire was advanced >5cm out of the catheter tip.Balloon leak occurred at the tip.Contrast ratio was 50/50.The guidewire tip was shaped by the physician.Injectio rate was steady.Syringe was a 1ml medallion.
 
Manufacturer Narrative
Additional information: device evaluation analysis found the hyperglide occlusion balloon catheter was returned for analysis within a shipping box; within two resealable pouches and without a dispenser coil.A guidewire was found within the balloon catheter and an rhv and 1ml syringe was attached to the hub.The guidewire was found stuck within the balloon catheter.The guidewire was found extending out from the balloon catheter ~6.8cm.When attempting to inflate the balloon using the returned syringe, a leak was found on the returned rhv.The rhv was replaced with an in-house rhv.A rupture was found on the balloon subassembly distal to the distal marker band.Water was found to be leaking out of the rupture.Based on the device analysis and reported information, the customer¿s report of ¿balloon rupture during procedure¿ was confirmed; however, the root cause could not be determined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYPERGLIDE
Type of Device
CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
MDR Report Key9214649
MDR Text Key207608084
Report Number2029214-2019-01046
Device Sequence Number1
Product Code MJN
Combination Product (y/n)N
PMA/PMN Number
K092495
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/04/2020
Device Model Number104-4310
Device Lot NumberA651288
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/24/2019
Initial Date Manufacturer Received 09/26/2019
Initial Date FDA Received10/21/2019
Supplement Dates Manufacturer Received11/21/2019
Supplement Dates FDA Received12/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-